ROCKEFELLER CAPITAL MANAGEMENT L.P. – Edwards Lifesciences Corporation Transaction History
ROCKEFELLER CAPITAL MANAGEMENT L.P. portfolio value:
$26.94M
portfolio value
ROCKEFELLER CAPITAL MANAGEMENT L.P. quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.31% | -4.31K shares | -4.47M | $82.63 | 326.04K |
| Q2 2022 | share | Increase | +0.79% | 2.60K shares | -7.17M | $95.09 | 330.36K |
| Q1 2022 | share | Increase | +0.23% | 765 shares | -3.77M | $117.72 | 327.76K |
| Q4 2021 | share | Increase | +2.01% | 6.43K shares | 6.07M | $130.68 | 326.99K |
| Q3 2021 | share | Decrease | -4.73% | -15.92K shares | 1.44M | $113.21 | 320.56K |
| Q2 2021 | share | Increase | +4.24% | 13.67K shares | 7.84M | $103.57 | 336.48K |
| Q1 2021 | share | Increase | +3.88% | 12.04K shares | -1.35M | $83.64 | 322.81K |
| Q4 2020 | share | Decrease | -7.27% | -24.35K shares | 1.60M | $91.23 | 310.76K |
| Q3 2020 | share | Decrease | -1.00% | -3.40K shares | 3.35M | $79.82 | 335.12K |
| Q2 2020 | share | Increase | +2.91% | 9.57K shares | 2.71M | $69.11 | 338.52K |
| Q1 2020 | share | Decrease | -3.49% | -11.88K shares | -5.82M | $62.87 | 328.94K |
| Q4 2019 | share | Increase | +0.36% | 1.23K shares | 1.61M | $77.76 | 340.83K |
| Q3 2019 | share | Increase | +1.54% | 5.16K shares | 4.3M | $73.3 | 339.59K |
| Q2 2019 | share | Decrease | -2.80% | -9.64K shares | -1.35M | $61.58 | 334.42K |
| Q1 2019 | share | Increase | +6.07% | 19.68K shares | 5.38M | $63.78 | 344.07K |
| Q4 2018 | share | Decrease | -1.94% | -6.42K shares | -2.63M | $51.06 | 324.38K |
| Q3 2018 | share | Increase | +0.04% | 144 shares | 3.15M | $58.03 | 330.80K |
| Q2 2018 | share | Decrease | -17.61% | -70.66K shares | -2.61M | $48.52 | 330.66K |
| Q1 2018 | share | Increase | 0.00% | 401.32K shares | 18.66M | $46.51 | 401.32K |